Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126071812 | 12607181 | 2 | F | 20150601 | 20160815 | 20160729 | 20160817 | EXP | GB-ROCHE-1648604 | ROCHE | 51.11 | YR | M | Y | 105.40000 | KG | 20160817 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126071812 | 12607181 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Subcutaneous | ON12/MAY/2015, 18/MAY/2015, 24/MAY/2015 AND 31/MAY/2015, HE RECIEVED 4 LAST DOSES PRIOR TO SAE.?TOTA | 1148278 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 126071812 | 12607181 | 2 | SS | Tocilizumab | TOCILIZUMAB | 1 | Subcutaneous | 1148278 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 126071812 | 12607181 | 3 | SS | Tocilizumab | TOCILIZUMAB | 1 | Subcutaneous | 1148278 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 126071812 | 12607181 | 4 | SS | Tocilizumab | TOCILIZUMAB | 1 | Subcutaneous | 1148278 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 126071812 | 12607181 | 5 | SS | Tocilizumab | TOCILIZUMAB | 1 | Subcutaneous | 1148278 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 126071812 | 12607181 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | QD | ||||||||||
| 126071812 | 12607181 | 7 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | 0 | |||||||||||
| 126071812 | 12607181 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | |||||||||||
| 126071812 | 12607181 | 9 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | |||||||||||
| 126071812 | 12607181 | 10 | C | IBUPROPHENUM | IBUPROFEN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126071812 | 12607181 | 1 | Rheumatoid arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126071812 | 12607181 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126071812 | 12607181 | 1 | 20150126 | 0 | ||
| 126071812 | 12607181 | 2 | 20150512 | 0 | ||
| 126071812 | 12607181 | 3 | 20150518 | 0 | ||
| 126071812 | 12607181 | 4 | 20150524 | 0 | ||
| 126071812 | 12607181 | 5 | 20150531 | 0 | ||
| 126071812 | 12607181 | 6 | 201501 | 0 | ||
| 126071812 | 12607181 | 7 | 2014 | 0 | ||
| 126071812 | 12607181 | 8 | 2014 | 0 | ||
| 126071812 | 12607181 | 9 | 20150604 | 20150704 | 0 | |
| 126071812 | 12607181 | 10 | 201501 | 0 |